The sexual medicine field has been in mode of revolution until recently. Like all other fields
of biomedical research, the economic situation around the world has had a negative impact …

Introduction: Phosphodiesterase type 5 inhibitors (PDE5Is) are the leading drugs for the
treatment of erectile dysfunction (ED), being recommended as a first line treatment by both …

Phosphodiesterase (PDE) enzymes are widely distributed throughout the body, having
numerous effects and functions. The use of on demand PDE5 inhibitors (-Is) for the treatment …

Abstract Phosphodiesterase type-5 (PDE-5) inhibitors are a new class of vasoactive drugs
that have been developed for treatment of erectile dysfunction (ED). The mechanism of …

To date, it is widely accepted that several disorders of the male and female urogenital tract,
such as erectile dysfunction, bladder overactivity, urinary stone disease, the benign prostatic …

Phosphodiesterase 5 inhibitors in male sexual dysfunction : Current Opinion in Urology
Phosphodiesterase 5 inhibitors in male sexual dysfunction : Current Opinion in Urology Log in …

Basic science research on erectile physiology has focused on the pathogenesis of erectile
dysfunction (ED) and has provided convincing evidence that ED is predominately a disease …

OBJECTIVE: Review the literature on phosphodiesterase type 5 inhibitors (PDE5-Is),
addressing critical issues in their current and future use, assessing unanswered questions …

This is our first presentation of Great Drug Classes, and we start with a description of
phosphodiesterase type 5 inhibitors and their use in erectile dysfunction. This is an in‐depth …

Erectile dysfunction (ED) increases in prevalence and severity because of aging processes
and related organic, iatrogenic and social problems. Decline of testosterone (T) levels is …